Category Innovation/ R&D

European Nuclear Lab CERN Launches New “Easy IP” Plan

Does the idea of a multifunctional, versatile position-sensitive detector for measuring characteristics of a beam of particles spark ideas for useful products of benefit to society and the economy? If so, then CERN has just the thing for you. In an attempt to boost the utility of its research, the European Organization for Nuclear Research (CERN), the Geneva-based intergovernmental laboratory, today announced a plan to offer its patented technologies for licence royalty-free in order to promote innovation.

World Health Assembly: Agreement Reached On Neglected Disease R&D Process, But No Convention

A proposal at this week’s World Health Assembly to negotiate a binding convention on research and development for neglected diseases - those predominantly afflicting poor populations - ran into resistance from developed countries which hold the view that another approach might be possible. But an agreement was reached on a way forward for the expert report that recommended the binding convention.

World Health Assembly: Latest Texts Of R&D Drafting Group

The latest available documents of the closed-door meeting addressing recommendations on ways to finance neglected diseases largely afflicting developing countries show progress heading into this afternoon's session. They reflect efforts to agree on how to take the process forward, including agreement reached last night on putting the issue to regional groups later this year.

World Health Assembly: R&D Drafting Group Documents Show Country Differences

A set of documents in use by today's closed-door negotiations on research and development for neglected diseases at the World Health Assembly lay out the core differences between WHO members. Negotiations are expected to last into the night as members try to agree on how to take forward recommendations from a key report - including to negotiate a binding convention on R&D for diseases left behind in the marketplace.